Device
UVB treatment
UVB treatment is a medical device with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
67%(2 trials)
Phase Distribution
Ph not_applicable
3
75%
Ph phase_2
1
25%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
3(75.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Other(1)
Detailed Status
Completed3
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (25.0%)
N/A3 (75.0%)
Trials by Status
completed375%
unknown125%
Recent Activity
0 active trials
Showing 4 of 4
completednot_applicable
Evaluating the Effect of SOLIUS UV Light Source in Improving Vitamin D Status
NCT04780776
completednot_applicable
Solius UV Light Source in Improving Serum Levels of 25-hydroxyvitamin D
NCT04865432
unknownnot_applicable
UVB-induced Treg Cells Exert Antigen-specific Suppression Through LAG-3
NCT05636839
completedphase_2
Epidermal Cell Transplantation in Vitiligo Skin
NCT01629979
Clinical Trials (4)
Showing 4 of 4 trials
NCT04780776Not Applicable
Evaluating the Effect of SOLIUS UV Light Source in Improving Vitamin D Status
NCT04865432Not Applicable
Solius UV Light Source in Improving Serum Levels of 25-hydroxyvitamin D
NCT05636839Not Applicable
UVB-induced Treg Cells Exert Antigen-specific Suppression Through LAG-3
NCT01629979Phase 2
Epidermal Cell Transplantation in Vitiligo Skin
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4